2011 2010 2009 2008
Elusys Awarded Additional $40.6 Million Under Exisiting US Government Contract To Fund Advanced Development Of Anthim, A New Treatment For Anthrax
Elusys Therapeutics and Lonza Extend Manufacturing Agreement For Anthim, a New Anthrax Treatment In Late-Stage Development
Elusys Receives Contract for up to $143 Million from the US Federal Government to Fund Advanced Development of Anthim®, a New Treatment for Anthrax
